Meeting report: Understanding the behavioural aspects and the role of health communication in mitigating the impact of seasonal influenza
The meeting report covers health communication strategies that could be undertaken to better promote influenza prevention measures and the healthcare professionals’ role in the uptake of seasonal influenza vaccination.
Review of outbreaks and barriers to MMR vaccination coverage among hard to reach populations in European countries
In recent years, substantial progress had been made towards eliminating measles, mumps and rubella in Europe. Measles vaccine coverage is on the rise and measles cases decreasing in many countries. However, there have still been several large outbreaks of measles, mumps and rubella reported in European countries.
Measles and rubella elimination: communicating the importance of vaccination
The goal of this project is to support EU Member States in their fight against measles and rubella. This report should enable Member States to engage in effective, evidence-based risk communication.
Let’s talk about hesitancy: enhancing confidence in vaccination and uptake
This guide provides practical evidence-based and peer-reviewed advice for public health programme managers and communicators involved with immunisation services. It identifies ways to enhance people’s confidence in vaccination and addresses common issues which underlie vaccination hesitancy.
Conducting health communication activities on MMR vaccination
This guide presents the reader with a host of ideas on how to effectively communicate on all issues that relate to measles, mumps and rubella (MMR) vaccination.
Case studies on preparedness planning for polio in Poland and Cyprus
The overall objective of this report is to support Poland and Cyprus in updating their polio preparedness planning as part of the two EU Member States' efforts at maintaining their polio-free status.
Infographic: Protect unborn babies from rubella
If a woman gets rubella shortly before getting pregnant or during the first three months of pregnancy, it is very likely to result in miscarriage or congenital anomalies known as congenital rubella syndrome (CRS).